Endo International PLC

Volume 164 · 164 F.T.C. 1059

Citation: 164 F.T.C. 1059
Docket: C-4539
Decision: 2017-07-03
Document type: other
Case type: antitrust
Industry: pharmaceuticals
Outcome: other
Relief: compliance_reporting; other
Source: Original volume PDF
Original PDF: This decision as a PDF

Cite this decision

Endo International PLC, 164 F.T.C. 1059 (2017). Consumer Law Library, https://consumerlawlibrary.org/decisions/v164-0018

Report an error in this record (decision id v164-0018)

Order status: unknown. Sunset may be extended by the latest qualifying federal-court complaint alleging an order violation; complaints, dismissal/appeal outcomes, and respondent-specific extensions are not fully tracked.

Cited by 0 later FTC decisions

Cites

Text (OCR of the scan at left; may contain errors)

IN THE MATTER OF ENDO INTERNATIONAL PLC Docket No. C-4539. Order, July 3, 2017 Letter appointing Quantic Regulatory Services LLC as Monitor. LETTER APPOINTING MONITOR George G. Gordon Dechert LLP RE: In re Endo Pharmaceuticals, et al., Case No. 17-cv-00312 Dear Mr. Gordon, This letter notifies Defendants that pursuant to Paragraph IV of the Stipulated Order for Permanent Injunction entered in the above-referenced matter the Federal Trade Commission has appointed Quantic Regulatory Services LLC as Monitor. The Commission has also approved the Monitor Agreement entered into among Quantic Regulatory Services, LLC and Endo Pharmaceuticals Inc. and Endo International plc. In according its approval, the Commission has relied upon the information submitted, and representations made, by Defendants and has assumed them to be accurate and complete. By direction of the Commission.

VOLUME 164 Interlocutory Orders, Etc.

← 164 F.T.C. 946 · 164 F.T.C. 1060 →